Ligand · 4T9
4T9 · N-(3,4-dimethoxyphenyl)-2-(1H-pyrazol-4-yl)-1H-pyrrolo[3,2-c]pyridin-6-amine
4T9, N-(3,4-dimethoxyphenyl)-2-(1H-pyrazol-4-yl)-1H-pyrrolo[3,2-c]pyridin-6-amine (C18 H17 N5 O2, 335.4 g/mol), in the MolNFT structures on GenesisL1: bound in 2 records (1 PDB entry). Every binding site with its residues within 4.5 Å, the…
- Component
- 4T9
- Formula
- C18 H17 N5 O2
- Class
- ligand
- Structures
- 2
- PDB entries
- 1
Binding sites
4T9 in 2 structures; the first of them:
- 4C4E · Structure-based design of orally bioavailable pyrrolopyridine inhibitors of the mitotic… · 4T9 A1796 · binds ILE531, VAL539, GLN541, ALA551, LYS553, ILE586, MET602, GLU603 and 8 more
- 4C4E · Structure-based design of orally bioavailable pyrrolopyridine inhibitors of the mitotic… · 4T9 A1796 · binds ILE531, VAL539, GLN541, ALA551, LYS553, ILE586, MET602, GLU603 and 8 more
Residues it binds most
ILE 2, ALA 2, ASN 2, ASP 2, CYS 2, GLN 2, GLU 2, GLY 2, LEU 2, LYS 2 (residue and the binding sites it lines).
Found with
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.